Cargando…
Validation of the picoAMH assay on the Dynex DS2 platform
OBJECTIVES: Anti-Müllerian hormone (AMH) is increasingly used as a biomarker of ovarian reserve in clinical practice, and is used both for management of fertility treatments and prediction of menopause. We sought to validate the newly FDA-approved Ansh Laboratories MenoCheck picoAMH ELISA on the Dyn...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804432/ https://www.ncbi.nlm.nih.gov/pubmed/31646166 http://dx.doi.org/10.1016/j.plabm.2019.e00140 |